Adenosine diphosphate-inducible platelet reactivity shows a pronounced age dependency in the initial phase of antiplatelet therapy with clopidogrel.
about
Antiplatelet resistance in strokeBlood cells: an historical account of the roles of purinergic signallingSafety of clopidogrel in older patients: a nonrandomized, parallel-group, controlled, two-centre study.Frequency of heparin/platelet factor 4-dependent platelet antibodies in patients undergoing angioplasty and stenting for cardiovascular disease and their role for on-clopidogrel platelet reactivity.Interleukin-6 and asymmetric dimethylarginine are associated with platelet activation after percutaneous angioplasty with stent implantation.Impact of platelet function test on platelet responsiveness and clinical outcome after coronary stent implantation: platelet responsiveness and clinical outcome.The risk of clopidogrel resistance is associated with ABCB1 polymorphisms but not promoter methylation in a Chinese Han populationDual antiplatelet therapy in patients with diabetes mellitus: special considerations.The Antiplatelet Effect of Clopidogrel Decreases With Patient Age.Clopidogrel: a pharmacogenomic perspective on its use in coronary artery disease.Disaggregation Following Agonist-Induced Platelet Activation in Patients on Dual Antiplatelet Therapy.Determinants to optimize response to clopidogrel in acute coronary syndromePotentiation of clopidogrel active metabolite formation by rifampicin leads to greater P2Y12 receptor blockade and inhibition of platelet aggregation after clopidogrel.Impact of advanced age on myocardial perfusion, distal embolization, and mortality patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitors.Comparison of 4 different strategies of DAPT after PCI in ACS real world population from a Northern Italy registry.Assessment of platelet-derived thrombogenicity with the total thrombus-formation analysis system in coronary artery disease patients receiving antiplatelet therapy.Calcium-Channel Blockers Attenuate the Antiplatelet Effect of Clopidogrel.
P2860
Q22305927-A3A270A3-D95A-4885-B3E1-DBD19F34CC18Q26799623-62D631F2-A0EB-4592-BE80-DD7B9C3AB335Q33393888-934B6540-D520-47A8-9B1D-C364CE8CD172Q33399119-55B62097-311D-45F9-A347-08B5D2A59EDAQ35216871-A14713DF-E8B6-4223-95F2-F64E80EC6341Q36078210-C0BD5ED4-A0BD-4399-A5AF-0755D45A0754Q36328226-DDA63E39-42D4-4F66-815B-51751A112EEDQ38087381-A108A933-B7FA-4D29-9E3A-5E9FA074601FQ40009280-58F8D2E0-B1E2-4D49-AD05-AEBB185181B9Q41141258-74584DAF-4686-4AF8-B06E-9973424B5730Q41620557-E37BEBB2-8BB0-4B12-B90E-943E7E9F7D9BQ41848961-3E0A8BB0-2B53-4AB3-BE05-2CA2AFE1C558Q43057004-72080536-E5D6-4CE0-90BA-CA31CB2E206FQ46290025-CFB5BCEF-19C6-4D4C-938D-136108F9FD68Q48636205-6DCC6B48-7002-4397-970A-A81C79A001DFQ51471743-8B52248F-096C-4BF1-B18B-FAB2E01D7726Q53224199-B77BD9DD-E83E-4B30-8A12-AB48616AA7DD
P2860
Adenosine diphosphate-inducible platelet reactivity shows a pronounced age dependency in the initial phase of antiplatelet therapy with clopidogrel.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Adenosine diphosphate-inducibl ...... elet therapy with clopidogrel.
@en
Adenosine diphosphate-inducibl ...... elet therapy with clopidogrel.
@nl
type
label
Adenosine diphosphate-inducibl ...... elet therapy with clopidogrel.
@en
Adenosine diphosphate-inducibl ...... elet therapy with clopidogrel.
@nl
prefLabel
Adenosine diphosphate-inducibl ...... elet therapy with clopidogrel.
@en
Adenosine diphosphate-inducibl ...... elet therapy with clopidogrel.
@nl
P2093
P1476
Adenosine diphosphate-inducibl ...... telet therapy with clopidogrel
@en
P2093
D Seidinger
R Koppensteiner
P2860
P356
10.1111/J.1538-7836.2009.03644.X
P577
2009-10-10T00:00:00Z